Other researches have shown that severe COVID-19 patients have a significant age-associated increase of autoantibody levels against 16 targets (e.g., amyloid β peptide, β catenin, cardiolipin, claudin, enteric nerve, fibulin, insulin receptor α, and platelet glycoprotein). This evidence concerns the gene INSR and COVID-19.